"tb prevention" blog posts
World Tuberculosis Day 2024: An update of our work at CROI
Every 24 March we commemorate World TB Day with the World Health Organisation. The theme for 2024 is ‘Yes! We can stop TB!’ and we wanted to update you on how we are playing our part in making that statement a reality.
Posted on: 22 March 2024
CELT celebrates Healthcare Science Week 2024 with Professor Saye Khoo
Healthcare Science Week is a week dedicated to celebrating the work of over fifty scientific specialisms and professional groups that make up the National Health Service’s diverse workforce.
Posted on: 15 March 2024
Dynamic partnerships for maximum impact: How our collaboration with Tandem Nano Ltd is fast-tracking our development programme
Maintaining adherence to medication is often a huge challenge to patients in low- and middle-income countries (LMICs). Reasons for poor adherence can be quite complex. They may run out of tablets and are unable to get a new supply, they may forget to take their medicine or they simply don’t like taking tablets daily due to the difficult side effects they can cause. Regardless of the reason for poor adherence, there is overwhelming evidence that supports the need for a different approach to healthcare within affected communities.
Posted on: 5 April 2023
Stopping TB in its tracks with long-acting injectables: A war of attrition
World TB Day 2023, themed 'Yes! We can end TB!', is set to inspire a renewed sense of hope in the fight against the TB epidemic. The campaign seeks to encourage leaders to take bold steps, increase funding, adopt innovative solutions, and act faster to curb the spread of the disease.
Posted on: 23 March 2023
Reducing the burden of TB in the world’s most in need communities with long-acting injectables
Ketho Angami is a member of the Global TB Community Advisory Board and Long-Acting Technologies Community Advisory Board. In 2016 he received the National Leadership AIDS Award in India, and also the Nagaland State Governor’s award in 2021. Ketho has been engaged in the field of community led advocacy for more than 15 years, working actively in the field of tuberculosis, HIV and viral hepatitis by holding governments accountable for preventable deaths from infectious diseases. He has been engaged with the grassroots population and generating community demands for quality of service on a human rights-based approach.
Posted on: 24 March 2022
Investing in TB prevention strategies with Long-Acting injectables
Susan Swindells is Professor of Internal Medicine in the Section of Infectious Diseases at the University of Nebraska Medical Center, USA. She is a contributing investigator on TB clinical development for the LONGEVITY project. A native of England, Dr. Swindells earned her medical degree from University College London in 1977, with postgraduate training in England and at the University of Washington in Seattle. A clinician and active researcher, Dr. Swindells has many years’ experience in HIV-related translational and clinical research, with a special interest in tuberculosis co-infection.
Posted on: 24 March 2022
Living with TB: My Experience
Monica was raised in a small town called Kohima in North East India. In 2015 she was diagnosed with TB for which she was treated for more than two years. Monica experienced a difficult treatment regimen which included daily injections for nine months and oral medication throughout the duration of her illness. Monica experienced many problems when living with TB including stigma and many difficult side-effects.
Posted on: 24 March 2022